Literature DB >> 15668761

[Adamantiades-Behcet's disease].

L Krause1.   

Abstract

Adamantiades-Behcet's disease (ABD) is a chronic recurrent vasculitis whose aetiology is still unclear. The first description goes back to B. Adamantiades und H. Behcet. The disease mainly occurs in Mediterranean, Middle and Far Eastern countries. However, it is not limited to these regions and can be found worldwide, and, as a result of increasing human mobility, is steadily becoming more significant. Clinical findings reveal recurrent oral and/or genital ulcers, arthritis and skin involvement in the form of erythema nodosum and superficial thrombophlebitis. Relapsing ocular involvement is one of the major manifestations in ABD and can be found in 60-80% of patients, resulting in retinal vasculitis, neuropathy or panuveitis. Eye involvement can lead to blindness in the affected eye in 20-50% of cases. Steroids, cyclosporin A und azathioprin are available to treat affected eyes. Studies of new treatment modalities including interferon-alpha or TNF antibodies are under way.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668761     DOI: 10.1007/s00347-004-1166-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  31 in total

1.  Behçet's syndrome.

Authors:  C G Barnes; H Yazici
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

2.  High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis.

Authors:  Christos C Zouboulis; Julia R Turnbull; Peter F Mühlradt
Journal:  J Invest Dermatol       Date:  2003-07       Impact factor: 8.551

3.  A historical review of Adamantiades-Behçet's disease.

Authors:  Christos C Zouboulis; Wolfgang Keitel
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

4.  Recent epidemiological data on Behçet's disease in Iran. The 2001 survey.

Authors:  F Shahram; F Davatchi; A Nadji; A Jamshidi; H Chams; C Chams; N Shafaie; M Akbarian; F Gharibdoost
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

Review 5.  Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.

Authors:  H Yazici; C G Barnes
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 6.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

7.  Treatment of Adamantiades-Behçet disease with systemic interferon alfa.

Authors:  C C Zouboulis; C E Orfanos
Journal:  Arch Dermatol       Date:  1998-08

8.  Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study.

Authors:  Vedat Hamuryudan; Yilmaz Ozyazgan; Yzzet Fresko; Cem Mat; Sebahattin Yurdakul; Hasan Yazici
Journal:  Isr Med Assoc J       Date:  2002-11       Impact factor: 0.892

Review 9.  Current therapy in Behcet's disease.

Authors:  T Sakane; M Takeno
Journal:  Skin Therapy Lett       Date:  2000

10.  Interferon therapy for Behçet's disease.

Authors:  E Alpsoy; E Yilmaz; E Başaran
Journal:  J Am Acad Dermatol       Date:  1994-10       Impact factor: 11.527

View more
  8 in total

1.  [Epidemiology of ocular involvement in Adamantiades-Behçets disease].

Authors:  C E Kneifel; A-K Köhler; A Altenburg; C C Zouboulis; L Krause
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

2.  Ocular involvement in Adamantiades-Behçet's disease in Berlin, Germany.

Authors:  Lothar Krause; Anne-Katrin Köhler; Andreas Altenburg; Nestor Papoutsis; Christos C Zouboulis; Uwe Pleyer; Andrea Stroux; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-04       Impact factor: 3.117

3.  Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.

Authors:  Moncef Khairallah; Sonia Attia; Salim Ben Yahia; Salah Jenzeri; Rim Ghrissi; Bechir Jelliti; Sonia Zaouali; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2008-03-26       Impact factor: 2.031

Review 4.  [Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics].

Authors:  U Pleyer; D Hazirolan; S Winterhalter; N Stübiger
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

5.  A study of the use of Behçet/Behçet's disease or syndrome with or without Adamantiades in the medical literature during the past two decades.

Authors:  Yaşar Barış Turgut; Gökhan Sargın
Journal:  Eur J Rheumatol       Date:  2020-11-19

6.  Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease.

Authors:  Lothar Krause; Andreas Altenburg; Nikolaos E Bechrakis; Gregor Willerding; Christos C Zouboulis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-13       Impact factor: 3.117

7.  [Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data].

Authors:  A Altenburg; A Mahr; C Maldini; C E Kneifel; L Krause; I Kötter; T Stache; N G Bonitsis; C C Zouboulis
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

8.  [Typical and atypical ocular manifestations of Behçet's disease].

Authors:  N Stübiger; U Pleyer
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.